| Literature DB >> 27069676 |
Azin Behnood-Rod1, Omid Rabbanifar2, Pirouz Pourzargar3, Alireza Rai4, Zahra Saadat3, Habibollah Saadat3, Yashar Moharamzad5, Donald E Morisky6.
Abstract
Introduction. Appropriate adherence to medication is still a challenging issue for hypertensive patients. We determined adherence to antihypertensive(s) and its associated factors among 280 Iranian patients. Methods. They were recruited consecutively from private and university health centers and pharmacies in four cities. The validated Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8) was administered to measure adherence. Results. Mean (±SD) overall MMAS-8 score was 5.75 (±1.88). About half of the sample (139 cases, 49.6%) showed low adherence (MMAS-8 score < 6). There was a negative linear association between the MMAS-8 score and systolic BP (r = -0.231, P < 0.001) as well as diastolic BP (r = -0.280, P < 0.001). In linear regression model, overweight/obesity (B = -0.52, P = 0.02), previous history of admission to emergency services due to hypertensive crisis (B = -0.79, P = 0.001), and getting medication directly from drugstore without refill prescription in hand (B = -0.51, P = 0.04) were factors recognized to have statistically significant association with the MMAS-8 score. Conclusion. Antihypertensive adherence was unsatisfactory. We suggest that health care providers pay special attention and make use of the aforementioned findings in their routine visits of hypertensive patients to recognize those who are vulnerable to poor adherence.Entities:
Year: 2016 PMID: 27069676 PMCID: PMC4812400 DOI: 10.1155/2016/1508752
Source DB: PubMed Journal: Int J Hypertens Impact factor: 2.420
Comparison of demographic characteristics between low and moderate/high adherence groups among 280 Iranian hypertensive patients.
| Total | Low adherence | Moderate/high adherence | Sig. | |
|---|---|---|---|---|
| Gender | ||||
| Male | 118 (42.1%) | 59 (50%) | 59 (50%) | 0.919 |
| Female | 162 (57.9%) | 80 (49.4%) | 82 (50.6%) | |
| Age, years | ||||
| ≤50 | 51 (18.2%) | 25 (49%) | 26 (51%) | 0.922 |
| >50 | 229 (81.8%) | 114 (49.8%) | 115 (50.2%) | |
| BMI, kg/m2 | ||||
| <25 | 76 (27.1%) | 28 (36.8%) | 48 (63.2%) | 0.011 |
| ≥25 | 204 (72.9%) | 111 (54.4%) | 93 (45.6%) | |
| Education | ||||
| Lower than high school diploma/illiterate | 164 (58.5%) | 86 (52.4%) | 78 (47.6%) | 0.008 |
| High school diploma | 71 (25.4%) | 40 (56.3%) | 31 (43.7%) | |
| Academic degree | 45 (16.1%) | 13 (28.9%) | 32 (71.7%) | |
| Occupation | ||||
| Market/self-employed | 73 (26.1%) | 43 (58.9%) | 30 (41.4%) | 0.001 |
| Clerk/military | 41 (14.6%) | 9 (22.0%) | 32 (78.0%) | |
| Housewife | 119 (42.5%) | 65 (54.6%) | 54 (45.4%) | |
| Retired/unemployed | 47 (16.8%) | 22 (46.8%) | 25 (53.2%) | |
| Current smoker | 49 (17.5%) | 29 (59.2%) | 20 (40.8%) | 0.141 |
| Insurance coverage | 246 (87.8%) | 119 (48.4%) | 127 (51.6%) | 0.253 |
| Residence place | ||||
| Urban | 273 (97.5%) | 133 (48.7%) | 140 (51.3%) | 0.053 |
| Rural | 7 (2.5%) | 6 (85.7%) | 1 (14.3%) |
Sig. = significance level.
Comparison of blood pressure variables between low and moderate/high adherence groups among 280 Iranian hypertensive patients.
| Total | Low adherers | Moderate/high adherers | Sig. | |
|---|---|---|---|---|
| HTN duration, mean (±SD), year | 7.23 (±5.97) | 7.06 (±5.71) | 7.40 (±6.23) | 0.966 |
| History of HTN crisis | 99 (35.3%) | 62 (62.5%) | 37 (37.4%) | 0.001 |
| BP measurement by a health care provider in the last 6 months | 230 (82.1%) | 107 (46.5%) | 123 (53.5%) | 0.025 |
| Self-awareness of BP | 161 (57.5%) | 81 (50.3%) | 80 (49.7%) | 0.795 |
| Mean systolic BP, mmHg | 136.7 (±16.2) | 139.6 (±15.2) | 133.8 (±16.8) | 0.003 |
| Mean diastolic BP, mmHg | 83.9 (±9.0) | 85.7 (±8.3) | 82.1 (±9.2) | <0.001 |
| Controlled BP in nondiabetics | 120 | 49 (40.8%) | 71 (59.2%) | <0.001 |
| Controlled BP in diabetics | 2 | 0 | 2 (100%) | 0.504 |
Comparison of number of antihypertensives and comorbidities between low and moderate/high adherence groups among 280 Iranian hypertensive patients.
| Total | Low adherers | Moderate/high adherers | Sig. | |
|---|---|---|---|---|
| Antihypertensive therapy | ||||
| Monotherapy | 127 (45.3%) | 68 (53.5%) | 59 (46.5%) | 0.234 |
| Combination therapy | 153 (54.6%) | 71 (46.4%) | 82 (53.6%) | |
| Number of antihypertensive(s) classes taken | ||||
| 1 | 127 (45.3%) | 68 (53.5%) | 59 (46.5%) | 0.079 |
| 2 | 95 (34%) | 37 (38.9%) | 58 (61.1%) | |
| 3–5 | 58 (20.7%) | 34 (58.6%) | 24 (41.4%) | |
| Presence of comorbidity | 160 (57.1%) | 77 (48.1%) | 83 (51.9%) | 0.629 |
| Mean (±SD) number of comorbidities, | 1.54 (±0.76) | 1.53 (±0.75) | 1.54 (±0.77) | 0.984 |
| Taking anti-hypertensive from pharmacy without doctor visit | 212 (75.7%) | 113 (53.3%) | 99 (46.7%) | 0.031 |
Linear regression analysis of variables associated with the MMAS-8 score.
|
| Standard error of | Significance | |
|---|---|---|---|
| History of HTN crisis | −0.796 | 0.228 | 0.001 |
| Taking antihypertensive from pharmacy without doctor visit | −0.515 | 0.251 | 0.041 |
| BMI ≥ 25 kg/m2 | −0.523 | 0.237 | 0.028 |
| Constant | 9.764 | 0.913 | 0.001 |
BMI = body mass index; HTN = hypertension.